What is HC Wainwright’s Estimate for LXRX Q1 Earnings?
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) – HC Wainwright issued their Q1 2025 EPS estimates for Lexicon Pharmaceuticals in a note issued to investors on Friday, March 7th. HC Wainwright analyst J. Pantginis anticipates that the biopharmaceutical company will post earnings per share of ($0.09) for the quarter. HC Wainwright currently has a “Buy” […]
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) – HC Wainwright issued their Q1 2025 EPS estimates for Lexicon Pharmaceuticals in a note issued to investors on Friday, March 7th. HC Wainwright analyst J. Pantginis anticipates that the biopharmaceutical company will post earnings per share of ($0.09) for the quarter. HC Wainwright currently has a “Buy” […]
